Bettina Bisig

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


87 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
In press
 
Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
Sarro R., Bisig B., Guey B., Missiaglia E., Cairoli A., Omoumi P., Letovanec I., Ferry J.A., Hasserjian R.P., de Leval L. Modern pathology. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8D5FC967934E]
2024
Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
Poullot E., Milowich D., Lemonnier F., Bisig B., Robe C., Pelletier L., Letourneau A., Dupuy A., Sako N., Ketterer N. et al., 2024/02. Histopathology, 84 (3) pp. 556-564. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_20A5DC090A70]
Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma - morphology, molecular characteristics and differential diagnosis.
Berezowska S., Maillard M., Keyter M., Bisig B., 2024/01. Histopathology, 84 (1) pp. 32-49. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A4D9C66D7F5E]
2023
Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient.
Anchisi S., Wolfer A., Bisig B., Missiglia E., Tiab A., Kamel E.M., Michielin O., Coukos G., Homicsko K., 2023/12/31. Cancer biology & therapy, 24 (1) p. 2193116. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_365141E36CC9]
Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions.
Bisig B., Savage K.J., De Leval L., 2023/12/01. Haematologica, 108 (12) pp. 3227-3243. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E8C6B65D96E1]
Was gibt es Neues bei der Klassifikation der peripheren T-Zell-Lymphomen? [What is new in the classification of peripheral T cell lymphomas?]
de Leval L., Bisig B., 2023/12. Pathologie, 44 (Suppl 3) pp. 128-135. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4D5C8209AD81]
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe.
Hofman P., Calabrese F., Kern I., Adam J., Alarcão A., Alborelli I., Anton N.T., Arndt A., Avdalyan A., Barberis M. et al., 2023/10. ESMO open, 8 (5) p. 101628. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_62232DE610EB]
 
EXABS-214-TCL New Insights Into the Pathogenesis of T-Cell Lymphoma and How This May Guide Treatment
de Leval Laurence, Bisig Bettina, 2023/09. Clinical Lymphoma Myeloma and Leukemia, 23 pp. S105-S106.
[DOI][WoS][serval:BIB_25A3009E07C9]
 
POSTER: TCL-330 RHOA G17V Potentiates CD28-Induced NFAT Transcriptional Activity by Modulating p300 Activity: A Step Further in the Understanding of Follicular Helper T-Cell Lymphoma
Vallois David, Juilland Mélanie, Kalliopi Ioannidou, Lemmonier François, Missiaglia Edoardo, Bisig Bettina, Thome Margot, de Leval Laurence, 2023/09. pp. S214 dans Clinical Lymphoma Myeloma and Leukemia, Elsevier BV.
[DOI][serval:BIB_B00CB4F58EB3]
ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study.
Sibon D., Bisig B., Bonnet C., Poullot E., Bachy E., Cavalieri D., Fataccioli V., Bregnard C., Drieux F., Bruneau J. et al., 2023/06/01. Haematologica, 108 (6) pp. 1590-1603. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3ECE36010A35]
MarrowQuant 2.0: A Digital Pathology Workflow Assisting Bone Marrow Evaluation in Experimental and Clinical Hematology.
Sarkis R., Burri O., Royer-Chardon C., Schyrr F., Blum S., Costanza M., Cherix S., Piazzon N., Barcena C., Bisig B. et al., 2023/04. Modern pathology, 36 (4) p. 100088. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_352A9711DE44]
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma.
Krebs F.S., Moura B., Missiaglia E., Aedo-Lopez V., Michielin O., Tsantoulis P., Bisig B., Trimech M., Zoete V., Homicsko K., 2023/02/24. International journal of molecular sciences, 24 (5) p. 4520. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E3A48A3138B7]
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.
Veloza L., Cavalieri D., Missiaglia E., Ledoux-Pilon A., Bisig B., Pereira B., Bonnet C., Poullot E., Quintanilla-Martinez L., Dubois R. et al., 2023/01/01. Haematologica, 108 (1) pp. 181-195. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_263F9CD467CA]
 
Perioperative Management of a Patient With Combined Bernard Soulier syndrome and Storage Pool Disease During On-Pump Cardiac Surgery.
Christophel-Plathier E., Costanza M., Kirsch M., Dulguerov F., Chapuis-Bernasconi C., Bisig B., Verdy F., Mendes V., Rancati V., Alberio L. et al., 2023/01. Journal of cardiothoracic and vascular anesthesia, 37 (1) pp. 90-95. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_243839C1BD54]
2022
 
HHV8-negative primary effusion-based large B-cell lymphoma in a patient with chronic myeloid leukemia, BCR::ABL1-positive under dasatinib treatment: Report of a new case and literature review.
Christe L., Veloza L., Gros L., Bisig B., Blum S., Hewer E., de Leval L., 2022/12. Diagnostic cytopathology, 50 (12) pp. E351-E356. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BFCAD836C568]
 
Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.
Bisig B., Cairoli A., Gaide O., Somja J., Bregnard C., Gaulard P., Xerri L., Lefort K., Missiaglia E., Gilliet M. et al., 2022/10. Virchows Archiv, 481 (4) pp. 653-657. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6CF9902CA42C]
 
Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.
Nicolae A., Bouilly J., Lara D., Fataccioli V., Lemonnier F., Drieux F., Parrens M., Robe C., Poullot E., Bisig B. et al., 2022/08. Modern pathology, 35 (8) pp. 1126-1136. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F6CBED5D1F0D]
EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders.
Veloza L., Tsai C.Y., Bisig B., Pantet O., Alberio L., Sempoux C., Cavassini M., de Leval L., 2022/03. Virchows Archiv, 480 (3) pp. 699-705. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_24812BA3BF72]
Isolated skin infiltration by a blastic plasmacytoid dendritic cell neoplasm.
Stalder G., Milowich D., Blum S., Schoumans J., Bisig B., Spertini O., 2022/02. EJHaem, 3 (1) pp. 259-260. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EC0E8BADE124]
2021
 
213 Genomic alteration of a metastatic gastric-type cervical adenocarcinoma: hints and personalized treatment options
Sarivalasis A, Bisig B, Hastir D, Lefort K, Liapi A, 2021/10. pp. A300 dans Pathology, BMJ Publishing Group Ltd.
[DOI][WoS][serval:BIB_EB50AFBF675C]
Postmortem Cardiopulmonary Pathology in Patients with COVID-19 Infection: Single-Center Report of 12 Autopsies from Lausanne, Switzerland.
Berezowska S., Lefort K., Ioannidou K., Ndiaye D.R., Maison D., Petrovas C., Rotman S., Piazzon N., Milowich D., Sala N. et al., 2021/07/28. Diagnostics, 11 (8) p. 1357. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_00E678B7BCC1]
 
Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome.
Trimech M., Letourneau A., Missiaglia E., De Prijck B., Nagy-Hulliger M., Somja J., Vivario M., Gaulard P., Lambert F., Bisig B. et al., 2021/06/01. The American journal of surgical pathology, 45 (6) pp. 773-786. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DC97D082A0AB]
Carcinome anaplasique de la thyroïde : nouvelles approches thérapeutiques [Anaplastic thyroid carcinoma : new therapeutic approaches]
Stamatiou A., Herrera-Gómez R.G., Szturz P., Bisig B., Romano E., Sykiotis G., Gorostidi F., La Rosa S., Kopp P., Cristina V., 2021/05/19. Revue medicale suisse, 17 (739) pp. 962-966. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E0FB351F6891]
Recent advances upper gastrointestinal lymphomas: molecular updates and diagnostic implications.
Foukas P.G., Bisig B., de Leval L., 2021/01. Histopathology, 78 (1) pp. 187-214. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A08FD6F43D89]
2020
Trametinib Induces the Stabilization of a Dual GNAQ p.Gly48Leu- and FGFR4 p.Cys172Gly-Mutated Uveal Melanoma. The Role of Molecular Modelling in Personalized Oncology.
Krebs F.S., Gérard C., Wicky A., Aedo-Lopez V., Missiaglia E., Bisig B., Trimech M., Michielin O., Homicsko K., Zoete V., 2020/10/28. International journal of molecular sciences, 21 (21) pp. E8021. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_44F221AEB60A]
MarrowQuant Across Aging and Aplasia: A Digital Pathology Workflow for Quantification of Bone Marrow Compartments in Histological Sections.
Tratwal J., Bekri D., Boussema C., Sarkis R., Kunz N., Koliqi T., Rojas-Sutterlin S., Schyrr F., Tavakol D.N., Campos V. et al., 2020/09/24. Frontiers in endocrinology, 11 p. 480. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_578B277669F9]
Meningeal Relapse of Nodular Lymphocyte Predominant Hodgkin Lymphoma Transformed to T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Case Report.
Salvioni Chiabotti P., Bisig B., Cairoli A., Hajdu S.D., Lovey P.Y., Milowich D., Ziadi S., Du Pasquier R., Brouland J.P., de Leval L., 2020/09/14. Frontiers in oncology, 10 p. 1745. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F7E269EA64DC]
Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay.
Drieux F., Ruminy P., Abdel-Sater A., Lemonnier F., Viailly P.J., Fataccioli V., Marchand V., Bisig B., Letourneau A., Parrens M. et al., 2020/06. Haematologica, 105 (6) pp. 1582-1592. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_99596E330272]
 
Macrofollicular Variant of Follicular Thyroid Carcinoma: A Rare Underappreciated Pitfall in the Diagnosis of Thyroid Carcinoma.
Bongiovanni M., Sykiotis G.P., La Rosa S., Bisig B., Trimech M., Missiaglia E., Gremaud M., Salvatori Chappuis V., De Vito C., Sciarra A. et al., 2020/01. Thyroid, 30 (1) pp. 72-80. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3593CD8A9C4E]
2019
Acinar cell carcinoma of the pancreas with thyroid-like follicular features: first description of a new diagnostic challenging subtype.
Saglietti C., Schneider V., Bongiovanni M., Missiaglia E., Bisig B., Dorta G., Demartines N., Sempoux C., La Rosa S., 2019/12. Virchows Archiv, 475 (6) pp. 789-794. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E4D0E1AAA380]
 
Deep Response to Anti-PD-1 Therapy of Metastatic Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumor With CD274/PD-L1 Amplification.
Özdemir B.C., Bohanes P., Bisig B., Missiaglia E., Tsantoulis P., Coukos G., Montemurro M., Homicsko K., Michielin O., 2019/12. JCO precision oncology, 3 pp. 1-6. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E12437A0DD54]
 
The Romand Network of Oncology: bridging the gap of personalised oncology
Michielin O., Tsantoulis P., Homicsko K., Christinat Y., De Leval L., Bisig B., Missiaglia E., Zoete V., Krebs F., Fortin A. et al., 2019/10/18. Swiss Medical Weekly.
[serval:BIB_2A3947B3BCE2]
 
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens.
Pisapia P., Malapelle U., Roma G., Saddar S., Zheng Q., Pepe F., Bruzzese D., Vigliar E., Bellevicine C., Luthra R. et al., 2019/05. Cancer cytopathology, 127 (5) pp. 285-296. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0DE727B0F676]
 
High-content, cell-by-cell assessment of HER2 overexpression and amplification: a tool for intratumoral heterogeneity detection in breast cancer.
Nguyen H.T., Migliozzi D., Bisig B., de Leval L., Gijs MAM, 2019/05. Laboratory investigation; a journal of technical methods and pathology, 99 (5) pp. 722-732. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3B1F249757F4]
 
Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease.
Chen B.J., Ruminy P., Roth C.G., Bisig B., Mankel B., Steinhilber J., Bohers E., Jardin F., Fend F., Swerdlow S.H. et al., 2019/01. The American journal of surgical pathology, 43 (1) pp. 110-120. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E32B64B55CF9]
2018
Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma.
Letourneau A., Maerevoet M., Milowich D., Dewind R., Bisig B., Missiaglia E., de Leval L., 2018/10. Virchows Archiv, 473 (4) pp. 505-511. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6CBA7C4E7F28]
La biopsie liquide, une nouvelle opportunité pour l’oncologie personnalisée [Liquid biopsy, a new opportunity for personalized oncology]
Astaras C., Dolcan A., Bisig B., Zaman K., 2018/05/16. Revue medicale suisse, 14 (607) pp. 1028-1032. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A01EBF6F6786]
The Bethesda System for Reporting Thyroid Cytopathology Explained for Practitioners: Frequently Asked Questions.
Bongiovanni M., Papadakis G.E., Rouiller N., Marino L., Lamine F., Bisig B., Ziadi S., Sykiotis G.P., 2018/05. Thyroid, 28 (5) pp. 556-565. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DA68FE57DD84]
Comment on "MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma".
Voruz S., Martins F., Cairoli A., Naveiras O., Homicsko K., Missiaglia E., de Leval L., Bisig B., Michielin O., Blum S., 2018/03. Haematologica, 103 (3) pp. e130. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0845E1BF99E5]
 
Angioimmunoblastic T-Cell Lymphoma
de Leval L., Bisig B., 2018. dans Encyclopedia of Pathology, Springer.
[DOI][serval:BIB_1CA9B5937013]
2017
 
Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.
Saldarriaga J., Bisig B., Couchy G., Castain C., Zucman-Rossi J., Balabaud C., Sempoux C., Bioulac-Sage P., 2017/12. Histopathology, 71 (6) pp. 989-993. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BABB8786FE0E]
 
P13: Breast implant-associated anaplastic large-cell lymphoma presenting as a tumor mass and recurring as a seroma, with dual JAK1 and STAT3 mutations
Bisig B., Letourneau A., Maerevoet M., Millowich D., Dewind R., Missiaglia E., de Leval L., 2017/10/20. p. 578 dans Swiss Pathology Days, Der Pathologe.
[serval:BIB_957A4B6ACCB5]
 
P8: Mucoepidermoid carcinoma of the palate presenting as an intraoral squamous papilloma. Description of a challenging case
Sarro R., Ziadi S., Gu C., Bongiovanni M., Bisig B., La Rosa S., 2017/10/20. pp. 575-576 dans Swiss Pathology Days, Der Pathologe.
[serval:BIB_F2012A4BE7DA]
B-cell lymphomas with discordance between pathological features and clinical behavior
de Leval Laurence, Copie-Bergman Christiane, Rosenwald Andreas, Rimsza Lisa, Pittaluga Stefania, Bisig Bettina, Dirnhofer Stefan, Facchetti Fabio, Pileri Stefano, Fend Falko et al., 2017/10. Virchows Archiv, 471 (4) pp. 439-451. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_23E4C01D31F6]
 
Analyse mutationnelle de BRCA1/2 et inhibiteurs de PARP chez les ­patientes atteintes de cancer de l'ovaire
Mertz Kirsten D., Bisig Bettina, Azzarello-Burri Silvia, Rauch Anita, Röthlisberger Benno, de Leval Laurence, Cathomas Gieri, Terracciano Luigi, Jochum Wolfram, Perren Aurel et al., 2017/09/20. Forum Médical Suisse ‒ Swiss Medical Forum, 17 (38) pp. 816-818.
[DOI][serval:BIB_19A0462F6458]
 
A standardized quantification tool for bone marrow components in histological sections
Tratwal J., Boussema C., Burri O., Koliqi T., Campos V., Nardi V., Bárcena C., Sarro R., Bisig B., De Leval L., 2017/09. pp. S62-S63 dans Experimental Hematology, Elsevier BV.
[DOI][serval:BIB_26E91B5D5E1A]
Du neuf dans l’oncogenèse moléculaire des lymphomes : rôle du gène SETD2 dans les lymphomes T de l’intestin [Molecular oncogenesis of lymphomas: role of the SETD2 gene in intestinal T-cell lymphomas]
Vallois D., Roberti A., Bisig B., Gaulard P., de Leval L., 2017/05. Medecine sciences, 33 (5) pp. 469-473. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4BD9DC2B89C0]
 
Malignant transformation of a β-catenin inflammatory adenoma due to an S45 β-catenin-activating mutation present 12 years before.
Sempoux C., Bisig B., Couchy G., Balabaud C., Zucman-Rossi J., Bioulac-Sage P., 2017/04. Human pathology, 62 pp. 122-125. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C5DE50D498E3]
 
Gray platelet syndrome: Novel mutations of the NBEAL2 gene.
Bottega R., Nicchia E., Alfano C., Glembotsky A.C., Pastore A., Bertaggia-Calderara D., Bisig B., Duchosal M.A., Arbesú G., Alberio L. et al., 2017/02. American journal of hematology, 92 (2) pp. E20-E22. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4F5F46E612D6]
 
Papillary thyroid carcinoma with nodular fasciitis-like stroma and β-catenin mutations should be renamed papillary thyroid carcinoma with desmoid-type fibromatosis.
Rebecchini C., Nobile A., Piana S., Sarro R., Bisig B., Gerasimos S.P., Saglietti C., Matter M., Marino L., Bongiovanni M., 2017/02. Modern pathology, 30 (2) pp. 236-245. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_52ED1FEDAE03]
 
Microfluidics-assisted fluorescence in situ hybridization for advantageous human epidermal growth factor receptor 2 assessment in breast cancer.
Nguyen H.T., Trouillon R., Matsuoka S., Fiche M., de Leval L., Bisig B., Gijs M.A., 2017/01. Laboratory investigation; a journal of technical methods and pathology, 97 (1) pp. 93-103. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2778C1344EC4]
2016
 
A436: Glutamine synthetase immunohistochemical staining patterns correlate with molecular abnormalities of b-catenin pathway in hepatocellular adenoma
Calderaro J., Sempoux C., Rebouissou S., Bisig B., Cappellen D., Le Bail B., Zucman-Rossi J., Balabaud C., Bioulac-Sage P., 2016/11/15. pp. 221A-222A dans 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Hepatology.
[WoS][serval:BIB_DD042E02780D]
 
Cutaneous presentation of hepatosplenic T-cell lymphoma-a potential mimicker of primary cutaneous gamma-delta T-cell lymphoma.
Karpate A., Barcena C., Hohl D., Bisig B., de Leval L., 2016/11. Virchows Archiv : an international journal of pathology, 469 (5) pp. 591-596. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7063D1F55B21]
Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer.
Dupouy D.G., Ciftlik A.T., Fiche M., Heintze D., Bisig B., de Leval L., Gijs M.A., 2016/02/09. Scientific reports, 6 p. 20277. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_97EC7850B286]
Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
Vallois D., Dobay M.P., Morin R.D., Lemonnier F., Missiaglia E., Juilland M., Iwaszkiewicz J., Fataccioli V., Bisig B., Roberti A. et al., 2016. Blood, 128 (11) pp. 1490-1502. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A7AD3DD77F83]
 
Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.
Vijgen S., Wyss C., Meylan P., Bisig B., Letovanec I., Manuel O., Pascual M., de Leval L., 2016. Transplantation, 100 (1) pp. 134-140. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2BE89E653468]
Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.
Roberti A., Dobay M.P., Bisig B., Vallois D., Boéchat C., Lanitis E., Bouchindhomme B., Parrens M.C., Bossard C., Quintanilla-Martinez L. et al., 2016. Nature Communications, 7 p. 12602. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C7743642D37E]
2015
 
Cerebriforms cells in cerebrum: an unusual finding
Sarro R., Gaide O., Letourneau A., Missiaglia E., Bisig B., Hottinger A., Cairoli A., de Leval L., 2015. p. 633 dans 81. Jahrestagung der Schweizerischen Gesellschaft für Pathologie, Der Pathologe.
[DOI][serval:BIB_D23B3416D5B0]
 
Non-small cell lung cancer: the prevalence of oncogenic driver mutations in Switzerland
Savic S., Eppenberger-Castori S., Bisig B., Cathomas G., Diebold J., Frattini M., Jochum W., Tischler V., Vassella E., Bubendorf L., 2015. p. 634 dans 81. Jahrestagung der Schweizerischen Gesellschaft für Pathologie, Der Pathologe.
[DOI][serval:BIB_BF837B04B303]
 
Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended.
Savic S., Diebold J., Zimmermann A.K., Jochum W., Baschiera B., Grieshaber S., Tornillo L., Bisig B., Kerr K., Bubendorf L., 2015. Lung Cancer (amsterdam, Netherlands), 89 (2) pp. 104-109. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E2AD569DD61F]
2014
Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly.
Somja J., Bisig B., Bonnet C., Herens C., Siebert R., de Leval L., 2014. Virchows Archiv, 464 (6) pp. 735-741. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_19B29CF3637B]
 
Primary γδ T cell lymphoma of the lung: report of a case with features suggesting derivation from intraepithelial γδ T lymphocytes [Primary gammadelta T cell lymphoma of the lung: report of a case with features suggesting derivation from intraepithelial gammadelta T lymphocytes].
Choe J.Y., Bisig B., de Leval L., Jeon Y.K., 2014. Virchows Archiv : An International Journal of Pathology, 465 (6) pp. 731-736. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F551024F9EE2]
2013
 
Cancers du sein chez l'homme: quatre cas avec différenciation neuroendocrine.
Nobile A., Viguet-Carin S., Matter M., Zaman K., Bisig B., Fiche M., 2013. dans 36e Assises de Pathologie.
[serval:BIB_47B020320798]
CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.
Bisig B., de Reyniès A., Bonnet C., Sujobert P., Rickman D.S., Marafioti T., Delsol G., Lamant L., Gaulard P., de Leval L., 2013. Haematologica, 98 (8) pp. 1250-1258.
[URN][DOI][WoS][Pmid][serval:BIB_4D39454DB37F]
 
Détermination per-opératoire de l'infiltration du myomètre par les carcinomes de l'endomètre: revue de l'expérience d'un centre (25 cas).
Kourda J., Bisig B., Barcena C., Fiche M., 2013. dans 36e Assises de Pathologie.
[serval:BIB_3B8219CC0DE5]
 
Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue.
El-Shazly A.E., Doloriert H.C., Bisig B., Lefebvre P.P., Delvenne P., Jacobs N., 2013. Clinical and Experimental Allergy : Journal of the British Society For Allergy and Clinical Immunology, 43 (3) pp. 322-331. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8553722AD6CC]
 
Rôle de l'examen extemporane des ganglions sentinelles des cancers du sein.
Kourda J., Nicoulaz A.L., Carel A., Bisig B., Delaloye J.F., Fiche M., 2013. dans 36e Assises de Pathologie.
[serval:BIB_AF635D476D2B]
2012
 
Two cases of male breast cancer with neuro-endocrine differentiation (FP32)
Nobile A., Matter M., Zaman K., Bisig B., Fiche M., 2012/11., 78. Annual Meeting of the Swiss Society of Pathology. St. Gallen, Switzerland, 8.-10. November 2012 pp. 580-581 dans Der Pathologe, Springer Medizin.
[serval:BIB_3F8860471D1E]
 
An Unusual Uterine Tumor With Signet Ring Cell Features.
Sarro R., Fiche M., Bisig B., Ketterer N., Benhattar J., Achtari C., de Leval L., 2012/03. International Journal of Gynecological Pathology, 31 (3) pp. 236-241.
[DOI][WoS][Pmid][serval:BIB_F61132BDA95C]
 
c-Maf expression in angioimmunoblastic T-cell lymphoma reflects follicular helper T-cell derivation rather than oncogenesis.
Bisig B., Thielen C., Herens C., Gofflot S., Travert M., Delfau-Larue M.H., Boniver J., Gaulard P., de Leval L., 2012. Histopathology, 60 (2) pp. 371-376. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C387A6CDAF5A]
 
CD30 expression in peripheral T-cell lymphomas, not otherwise specified: is it relevant for the identification of distinct subgroups?(LYS011)
Bisig B., de Leval L., Risckman D.S., Sujobert P., Bonnet Ch., Marafioti T., Delsol G., Lamant L., Gaulard Ph., 2012. pp. 220-221 dans XVI Meeting of the European Association for Haematopathology 2012, Journal of Hematopathology.
[serval:BIB_AC68B164B0EA]
 
Does introduction of thresholds in decision aids benefit the patient?: Comparison between findings-based and threshold-based diagnostic decision aids.
Bisig B., Moreira J., Combes M., Asiimwe A., Bisoffi Z., Haegeman F., Bottieau E., Van den Ende J., 2012. Medical Decision Making : An International Journal of the Society For Medical Decision Making, 32 (6) pp. E16-E34. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A0B03699BC9E]
 
Is increasing complexity of algorithms the price for higher accuracy? virtual comparison of three algorithms for tertiary level management of chronic cough in people living with HIV in a low-income country.
Mukabatsinda C., Nguyen J., Bisig B., Lynen L., Coppens Y.D., Asiimwe A., Van den Ende J., 2012. Bmc Medical Informatics and Decision Making, 12 p. 2. Peer-reviewed.
[DOI][Pmid][serval:BIB_9B7371052D53]
 
New biomarkers in T-cell lymphomas.
Bisig B., Gaulard P., de Leval L., 2012. Best Practice and Research. Clinical Haematology, 25 (1) pp. 13-28. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BCB15991DCF2]
 
Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: implications for tumor recurrence.
Dejeans N., Glorieux C., Guenin S., Beck R., Sid B., Rousseau R., Bisig B., Delvenne P., Buc Calderon P., Verrax J., 2012. Free Radical Biology and Medicine, 52 (6) pp. 993-1002.
[DOI][WoS][Pmid][serval:BIB_E09E6A1DF757]
 
Type II enterpathy-associated T-cell lymphoma: report of a european series(LYS018)
de Leval L., Parrens M., Bouchindhomme B., Moreau A., Bossard C., Molina Th., Delfau M.-H., Gaulard Ph., 2012. pp. 225-226 dans XVI Meeting of the European Association for Haematopathology 2012, Journal of hematopathology.
[serval:BIB_26213A004B17]
2011
 
CHIC cells: a novel ALK+ cell line derived from a relapsed anaplastic large cell lymphoma.
Thielen C., Bisig B., Gofflot S., Herens C., Fillet G., Jamar M., Tassin F., Boniver J., Drion P., de Leval L., 2011. British Journal of Haematology, 152 (3) pp. 356-360.
[DOI][Pmid][serval:BIB_90D06A046D50]
 
Human papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretion.
Renoux V.M., Bisig B., Langers I., Dortu E., Clémenceau B., Thiry M., Deroanne C., Colige A., Boniver J., Delvenne P. et al., 2011. European Journal of Immunology, 41 (11) pp. 3240-3252. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0821670842B2]
 
Primary central nervous system lymphoma in a patient treated with natalizumab.
Phan-Ba R., Bisig B., Deprez M., De Prijck B., Delrue G., Herens C., Moonen G., Belachew S., de Leval L., 2011. Annals of Neurology, 69 (6) pp. 1060-1; author reply 1061-2.
[DOI][WoS][Pmid][serval:BIB_0211F8C0874F]
2010
 
Fish and chips [Fish and chips].
Delvenne P., Deprez M., Bisig B., Jamar M., Boniver J., Bours V., Herens C.h., 2010. Revue Médicale De Liège, 65 Spec no. pp. 3-10. Peer-reviewed.
[Pmid][serval:BIB_2AB6D50017E2]
 
Local applications of GM-CSF induce the recruitment of immune cells in cervical low-grade squamous intraepithelial lesions.
Hubert P., Doyen J., Capelle X., Arafa M., Renoux V., Bisig B., Seidel L., Evrard B., Bousarghin L., Gerday C. et al., 2010. American Journal of Reproductive Immunology (new York, N.y. : 1989), 64 (2) pp. 126-136. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_930252EF2383]
2009
 
Molecular classification of T-cell lymphomas.
de Leval L., Bisig B., Thielen C., Boniver J., Gaulard P., 2009. Critical Reviews In Oncology/hematology, 72 (2) pp. 125-143.
[DOI][Pmid][serval:BIB_2F1BA4F65769]
 
Primary mucosa-associated lymphoid tissue lymphoma of the gallbladder: report of a case harboring API2/MALT1 gene fusion.
Bisig B., Copie-Bergman C., Baia M., Gaulard P., Delbecque K., Fassotte M.F., Boniver J., de Leval L., 2009. Human Pathology, 40 (10) pp. 1504-1509.
[DOI][Pmid][serval:BIB_406D727FDB0A]
 
Weighing harm in therapeutic decisions of smear-negative pulmonary tuberculosis.
Moreira J., Bisig B., Muwawenimana P., Basinga P., Bisoffi Z., Haegeman F., Kishore P., Van den Ende J., 2009. Medical Decision Making : An International Journal of the Society For Medical Decision Making, 29 (3) pp. 380-390. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FC9B8FE0E2F8]
2008
 
Characterization of CD4+CD57+tumor-infiltrating lymphocytes in follicular lymphoma (LS 172)
Thielen C., Goval J.J., Bisig B., Gofflot S., Boniver J., de Leval L., 2008. p. 245 dans Bone Marrow Symposium 20-25 September 2008, Bordeaux France, Journal of Hematopathology, XIV. Meeting of the European Association for Haematopathology.
[serval:BIB_34315AB0EFCA]
 
Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression.
Herens C., Lambert F., Quintanilla-Martinez L., Bisig B., Deusings C., de Leval L., 2008. Blood, 111 (3) pp. 1745-1746.
[DOI][Pmid][serval:BIB_C49A1EA1DA85]
2007
 
Why are clinicians reluctant to treat smear-negative tuberculosis? An inquiry about treatment thresholds in Rwanda.
Basinga P., Moreira J., Bisoffi Z., Bisig B., Van den Ende J., 2007. Medical Decision Making : An International Journal of the Society For Medical Decision Making, 27 (1) pp. 53-60. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_40C8F948A734]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University